Research shows that the 'Friday Effect' is real. Drug safety alerts released on Fridays had less impact on medication consumption and submissions to drug-safety database than other weekdays. FDAAlert MedTwitter
Anupam B. Jena, MD, PhD, a professor at Harvard Medical School, Boston, and the host of theJena featured the study on his podcast"not only because the study's findings were so intuitive and interesting but because unlike most issues in healthcare, there seemed to be an easy fix," he toldHave regulators have gotten the message?
Notifications might include information about serious or life-threatening adverse events discovered after a drug is on the market, additional details about a known adverse event, a new contraindication, previously unknown drug interactions, or medication errors that could cause serious reactions, Kohler said.
"It has been our policy to issue drug-safety alerts as soon as we have all the available information," Kohler said."Time is a critical factor in drug safety and we can't delay or hold on to critical safety information.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA approves treatment that ALS Ice Bucket Challenge helped fundIn 2014, people all over the world joined in on the ALS ice bucket challenge. It raised $115 million in donations, according to the ALS Association.
Consulte Mais informação »
FDA Approves HIV-1 Treatment Ibalizumab for 30-Second IV PushThe medication was first approved by the FDA in 2018 for adults with multi-drug resistant HIV-1.
Consulte Mais informação »
Advocates Urge FDA to Ease Access to Abortion Pill for Miscarriage ManagementMedical and advocacy groups are urging the FDA to add miscarriage management as a use case for mifepristone, a drug commonly used in medical abortions, and ease the restrictions around who can prescribe it. Via 19thnews
Consulte Mais informação »
FDA Approves Futibatinib for Certain Biliary Tract CancersFDAapproves futibatinib, to be used for patients with previously treated, unresectable, locally advanced, or metastatic intrahepatic cholangiocarcinoma, through its accelerated approval program. OncTwitter MedTwitter
Consulte Mais informação »
Juul Prepares to Seek Financing for Potential Bankruptcy ProcessJuul Labs is expected as soon as this week to start discussions with lenders for financing that would carry the vaping company through a potential chapter 11 bankruptcy filing
Consulte Mais informação »